Atrial natriuretic peptide (ANP) is similar to b-type natriuretic peptide (BNP) in the hemodynamic effects. ANP is not measured clinically unlike BNP. It is released in response to myocyte stretch ...

E-Star BioTech, LLC (“E-Star” or the “Company”), an innovative developer of novel peptides designed to treat cardiovascular, ...

BNP is similar to atrial natriuretic peptide (ANP), however ANP is not as easily measured. The initial primary use of measuring b-type natriuretic peptide (BNP) is to determine the etiology of ...

The chambers release peptide hormones, including ‘atrial natriuretic peptide’ and ‘brain natriuretic peptide’, which help regulate the balance of fluid in the body by affecting the kidneys.

Obesity influences the thresholds, but even in nonobese patients with dyspnea, optimal cutoffs may be lower than recommended.

Luís Beck-da-Silva, MD; Adolfo de Bold, PhD, FRSC; Ross A. Davies, MD, FRCPC; Benjamin J.W. Chow, MD, FRCPC; Terrence D. Ruddy, MD, FRCPC; Margaret Fraser, RN ...

The left atrial phasic functions and the relationship with plasma N-terminal pro-B-type natriuretic peptide levels and symptomatic states in patients with hypertrophic cardiomyopathy. Home blood ...

today announced that it has dosed its first patient in a Phase 2 clinical trial of Modified Atrial Natriuretic Peptide (MANP) for the treatment of Resistant Hypertension (BOLD-HTN). MANP was ...